Last reviewed · How we verify
NCT04297800: GECO-PD
Gait Characteristics and Cognitive Evolution in Parkinson Disease
trial in Parkinson's Disease in 60 participants. Completed in 31 December 2024.
30 November 2023
Quick facts
| Lead sponsor | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 9 November 2019 |
| Primary completion | 30 November 2023 |
| Estimated completion | 31 December 2024 |
| Sites | 3 locations across Italy |
Conditions studied
- Parkinson's Disease — all drugs for Parkinson's Disease →
Sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS — full company profile →
Who can join
Adults 55 to 74, any sex, with Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkinson's disease (PD) is a chronic progressive nervous system disease with gradual motor impairment. Cognitive dysfunction is common in PD, even in the early stages, and it is characterized by impairments in executive, attention, memory, language and visuospatial function. Motor symptoms, in particular, alterations in gait, have been studied in clinical practice to assess disease progression, and its response to treatments, both farmacological and physiotherapeutic. Recent research on wearable technology in PD has shown that motor tests can be automated using wearable technology to eliminate human supervision and patient-reported data. Particularly, the quantitative gait analysis by using inertial devices has been proposed as a sensitive tool to longitudinally monitor gait worsening, response to dopaminergic treatment over time and cognitive dysfunction in PD patients. The aim of this prospective multicente observational study is to investigate whether the dysfunction of specific gait parameters may be correlated to cognitive impairment (Attention/Executive Function Domain) in a cohort of ambulatory PD patients followed for 3 years.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparing the Informative Value of 2-Minute Segments of the 6-Minute Walk Test: Insights into a Prospective Study on Parkinson's Disease.
Zangari R, Brighina L, Pilotto A, Carioli G, et al · · 2025 · cited 1× · PMID 41305283 · DOI 10.3390/s25227076
Verify or expand the search:
- PubMed search for NCT04297800
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson's Disease
Currently open trials in the same condition.
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07330258 — A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite · recruiting
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
- NCT06562569 — Non-invasive VNS for PD Gait · NA · recruiting
Other FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS trials
Trials by the same sponsor.
- NCT07203768 — A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes · recruiting
- NCT07317011 — "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico. · recruiting
- NCT07442760 — ePro Diary - HDV ( MACROLIVER ) · recruiting
- NCT06626685 — Clonal Hematopoiesis of Indeterminate Potential in Heart Failure. · recruiting
- NCT06752941 — LOW-PV Continuation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04297800 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- Last refreshed: 8 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04297800.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing